Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IONSĀ – Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.
IONS
$43.03
Name : Ionis Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,858,594,816.00
EPSttm : -1.76
finviz dynamic chart for IONS
Ionis Pharmaceuticals, Inc.
$43.03
0.12%
$0.05

Float Short %

8.3

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

-1.6

EPS Last/This Y

0.74

EPS This/Next Y

0.39

Price

43.03

Target Price

58.25

Analyst Recom

1.69

Performance Q

35.7

Relative Volume

1.33

Beta

0.25

Ticker: IONS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04IONS43.190.431.5828474
2025-07-07IONS41.780.430.8928614
2025-07-08IONS41.340.450.0629796
2025-07-09IONS42.830.440.7029911
2025-07-10IONS42.340.450.2130029
2025-07-11IONS41.740.450.4630018
2025-07-14IONS42.580.450.0230056
2025-07-15IONS42.010.440.0031522
2025-07-16IONS42.770.430.9131623
2025-07-17IONS42.160.440.0031680
2025-07-18IONS41.750.440.4331683
2025-07-21IONS41.570.320.1324611
2025-07-22IONS41.970.320.0124649
2025-07-23IONS42.370.320.1224705
2025-07-24IONS42.140.320.1424855
2025-07-25IONS42.240.320.6924873
2025-07-28IONS41.210.321.6325320
2025-07-29IONS41.430.334.8225657
2025-07-30IONS43.350.340.0125830
2025-07-31IONS42.990.330.7726489
2025-08-01IONS43.030.350.5927674
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04IONS43.00154.8-75.5-2.29
2025-07-07IONS41.78154.8-67.8-2.29
2025-07-08IONS41.34154.8-77.1-2.29
2025-07-09IONS42.83154.8-101.2-2.29
2025-07-10IONS42.38154.8-77.1-2.29
2025-07-11IONS41.73154.8-69.3-2.29
2025-07-14IONS42.55154.8-92.7-2.29
2025-07-15IONS42.00154.8-75.9-2.29
2025-07-16IONS42.78154.8-92.1-2.29
2025-07-17IONS42.17154.8-75.3-2.29
2025-07-18IONS41.76154.8-77.5-2.29
2025-07-21IONS41.55154.8-79.9-2.29
2025-07-22IONS41.95154.8-87.6-2.29
2025-07-23IONS42.38154.8-87.8-2.29
2025-07-24IONS42.15169.1-79.7-2.29
2025-07-25IONS42.24169.1-83.7-2.30
2025-07-28IONS41.33169.1-71.2-2.30
2025-07-29IONS41.48169.1-86.4-2.30
2025-07-30IONS43.37169.1-106.2-2.30
2025-07-31IONS42.98-22.4-92.8-2.30
2025-08-01IONS43.03-22.4-269.8-2.30
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04IONS-3.774.639.16
2025-07-07IONS-3.774.669.16
2025-07-08IONS-3.774.669.16
2025-07-09IONS-3.774.669.16
2025-07-10IONS-3.774.669.16
2025-07-11IONS-3.774.669.11
2025-07-14IONS-3.774.709.11
2025-07-15IONS-3.774.709.11
2025-07-16IONS-3.794.709.11
2025-07-17IONS-3.794.709.11
2025-07-18IONS-1.574.709.11
2025-07-21IONS-1.574.729.11
2025-07-22IONS-1.564.729.11
2025-07-23IONS-1.564.729.11
2025-07-24IONS-1.564.729.11
2025-07-25IONS-1.574.728.30
2025-07-28IONS-1.574.848.30
2025-07-29IONS-1.574.848.30
2025-07-30IONS-1.574.848.30
2025-07-31IONS-1.574.848.30
2025-08-01IONS-1.634.848.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

0.7

Avg. EPS Est. Current Quarter

-0.89

Avg. EPS Est. Next Quarter

-0.9

Insider Transactions

-1.63

Institutional Transactions

4.84

Beta

0.25

Average Sales Estimate Current Quarter

155

Average Sales Estimate Next Quarter

169

Fair Value

Quality Score

43

Growth Score

41

Sentiment Score

59

Actual DrawDown %

33.2

Max Drawdown 5-Year %

-60

Target Price

58.25

P/E

Forward P/E

PEG

P/S

7.26

P/B

10.84

P/Free Cash Flow

EPS

-1.85

Average EPS Est. Cur. Y​

-2.3

EPS Next Y. (Est.)

-1.9

Target Price Estimates Raised

2

Target Price Estimates Lowered

Profit Margin

-28.36

Relative Volume

1.33

Return on Equity vs Sector %

-66.2

Return on Equity vs Industry %

-47.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-269.8
Ionis Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 1069
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); Donidalorsen for patients with hereditary angioedema; and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 that has completed Phase 2 clinical trial for the potential treatment of AS, a rare genetic neurological disease. In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a); Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus; Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as other mid-stage pipeline investigational medicines. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with Metagenomi. The company was incorporated in 1989 and is headquartered in Carlsbad, California.
stock quote shares IONSĀ – Ionis Pharmaceuticals, Inc. Stock Price stock today
news today IONSĀ – Ionis Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IONSĀ – Ionis Pharmaceuticals, Inc. yahoo finance google finance
stock history IONSĀ – Ionis Pharmaceuticals, Inc. invest stock market
stock prices IONS premarket after hours
ticker IONS fair value insiders trading